Analysts Disagree Over Significance Of Akorn Inc’s Financial Errors
April 28, 2015 at 09:59 AM EDT
Akorn, Inc. (NASDAQ: AKRX) will have to restate financials from 2014 due to accounting error. Though the pharmaceutical company affirmed its 2015 earnings per share guidance, the stock fell by more than 20% on Monday following the announcement.
